Introductions to the latest additions to the AMS website are shown here.
Members should log in to see the Members's only content on this page.
-
Since most women will continue working for years after entering menopause, the effect of menopause symptoms on their working ability is an important issue and the focus of a new study. Among other things, the study suggested that premature menopause can limit a woman’s work ability and time spent...
Read more...
-
15 April 2024
Summary
Palacios et al. recently published a review on obesity and menopause [1]. Obesity is a clear-cut, worldwide, very common health problem which relates to increased incidence of various diseases, mainly cardiovascular. The paper summarizes the relevant literature until the end of...
Members Login to Read more...
-
18 March 2024
Summary
Stress urinary incontinence (SUI) is a common health problem that affects more or less 35% of women in the reproductive period. Gaspar et al. [1] conducted a prospective uncontrolled study in order to assess the long-term efficacy and safety of a non-ablative Er:YAG laser...
Members Login to Read more...
-
February 26, 2024
Summary
Several studies have reported racial/ethnicity differences in the prevalence of vasomotor symptoms (VMS), sleep disturbance and VMS treatment for menopause. In order to assess the reproducibility of these differences, recently Kingsberg et al. [1] systematically reviewed...
Members Login to Read more...
-
AMS is excited to announce that we will be hosting Menopause Down Under at Rydges World Square, Sydney on Saturday 6 April 2024. This whole day event will focus on midlife women's health issues down under. Join us for an up-to-date discussion on the fundamentals of menopause medicine, management...
Read more...
-
From the Cancer Australia Website
https://www.canceraustralia.gov.au/cancer-types/breast-cancer/overview
Understanding risk
Cancer Australia has a dedicated website Breast Cancer The risk factors that provides comprehensive information concerning risk.
"As a woman, over the course of your lifetime...
Read more...
-
Australia
Please note that Femoston-Conti 1/5 has been delisted from the PBS and is only available on private script from 1 December 2023. Patients who have been prescribed Femoston-Conti 1/5 before 1 December 2023 will be able to have it dispensed at the PBS listed price until 1 March 2024. We...
Read more...
-
Dr Ekta KapoorAssociate Professor of Medicine at Mayo Clinic College of Medicine in Rochester, Minnesota.
Dr Kapoor discusses premature and early menopause and the long-term effects of estrogen deprivation. She reviews the causes of premature menopause, the importance of counseling ad pregnancy...
Members Login to Read more...
-
Genitourinary syndrome of menopause (GSM) affects up to 84% of women. Because GSM does not improve over time, many of those affected may have symptoms for decades if left untreated. Symptoms can be distressing and uncomfortable and can significantly affect quality of life. Some medications for GSM...
Members Login to Read more...
-
27 November 2023
Summary
Recently, Sánchez-Zarza et al. [1] aimed at determining the prevalence of menopausal symptoms and factors related to severity in mid-aged women from Asunción, Paraguay. For this, they carried out a cross-sectional study in which 216 urban-living women (40-60 years) were...
Members Login to Read more...
-
21 November 2023
Summary
During the postmenopausal stage women often display adverse lipid profiles; however, evidence is insufficient regarding the association between lipids and reproductive aging in Korean women. Bearing this in mind, Park et al. [1] aimed to characterize lipid changes in...
Members Login to Read more...
-
Dr Sharon BoberSenior psychologist at the Dana-Farber Cancer Institute and associate professor in the department of psychiatry at Harvard Medical School in Boston, Massachusetts. She is also the founding director of the Dana-Farber Sexual Health Program.
Dr Bober discusses changes in sexual health...
Members Login to Read more...
-
Dr Sharon BoberSenior psychologist at the Dana-Farber Cancer Institute and associate professor in the department of psychiatry at Harvard Medical School in Boston, Massachusetts. She is also the founding director of the Dana-Farber Sexual Health Program.
Dr Bober reviews sexual health during and...
Members Login to Read more...
-
Dr Erin Michos, is associate professor of medicine within the Division of Cardiology at the Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She also is the director of women's cardiovascular health and...
Read more...
-
September 18th, 2023
Summary
There has been an increase in the use of non-hormonal options to treat hot flashes among many menopausal women, basically due to the potential risks of long-term systemic estrogen therapy. Physiologic studies have shown that nitric oxide is pivotal in mediating...
Members Login to Read more...
-
Cardiovascular disease (CVD) is the leading cause of death in women. Adverse pregnancy outcomes, including hypertensive disorders of pregnancy, gestational diabetes mellitus, preterm delivery, and low birth weight—affecting up to 30% of pregnant women—increase the risk of CVD. Early menarche and...
Members Login to Read more...
-
By Dr Sylvia Rosevear
As I write this, we are coming up to remarkable record of 600 delegates at the 26th Annual Australasian Menopause Congress in Queenstown, New Zealand 1-3 September, 2023 at The Millennium Hotel, with a view of ‘The Remarkables’, named because they are in a straight line from...
Members Login to Read more...
-
24 July 2023
Summary
The vagina has traditionally been conceived as a passive female reproductive organ that serves basically as a passageway for menstrual blood, sexual intercourse and childbirth. However, recent research, as revised by Cipriani et al. [1], has provided insights on the role of...
Members Login to Read more...
-
10 July 2023
Summary
Recently, Muka et al. [1] carried out a prospective cohort study that aimed at examining the association between the age at natural menopause and the risk of developing type 2 diabetes. For this, 3,639 postmenopausal women of the Rotterdam population based study were included. Age of...
Members Login to Read more...
-
26 June 2023
Summary
Reports indicate that the visceral adiposity index (VAI) is useful to predict cardiovascular disease (CVD) and the metabolic syndrome (MetS). Despite this, long-term studies that analyze the efficacy of the VAI in the prediction of CVD risk are limited and the association...
Members Login to Read more...